IRCT20221211056777N4招募中3 期
Effect of coenzyme Q10 supplement to decrease cardiac complications predictor factors in ß-Thalassemia major patients
Shahre-kord University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Beta Thalassemia major
- •Informed consent to participate in the intervention
- •No history of underlying disease
- •Not to use other supplements
排除标准
- •Pregnancy or breastfeeding
研究者
相似试验
进行中（未招募）
3 期
Coenzyme Q10 for dementiaDementiaJPRN-jRCTs061180062ABE SATOSHI100
招募中
不适用
The efficacy of reduced form of coenzyme Q10 in the Treatment of dementiaDemenitaJPRN-UMIN000019587Shimane University100
已完成
不适用
Effect of the REduced form of COenzyme Q10 Supplementation on endothelial function in chronic heart failurechronic heart failureJPRN-UMIN000012604Yokohama City University Medical Center20
已完成
不适用
Evaluation of the effects of Coenzyme Q10 on the serum concentration of interleukin 6 and interleukin 33 in hemodialysis patientsEnd Stage Renal Disease (Hemodialysis).Chronic kidney disease, stage 5 Chronic uraemia End stage kidney disease: in allograft failure NOS on dialysis without dialysis or transplantIRCT2015061722637N2Vice chancellor for research, Kerman University of Medical Sciences130
尚未招募
1 期
Evaluation the effect of co-enzyme Q10 in patients with thalassemia majorthalassemia major.Beta thalassemiaD56.1IRCT20221211056777N1Shahre-kord University of Medical Sciences50